SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001213900-22-076486
Filing Date
2022-12-01
Accepted
2022-11-30 19:00:03
Documents
17

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 3 TO FORM S-1 ea169248-s1a3_felicitex.htm S-1/A 2106930
2 FORM OF INVESTOR WARRANT ea169248ex4-3_felicitex.htm EX-4.3 174157
3 OPINION OF BEVILACQUA PLLC ea169248ex5-1_felicitex.htm EX-5.1 24058
4 CONSENT OF FRIEDMAN LLP ea169248ex23-1_felicitex.htm EX-23.1 1996
5 GRAPHIC image_001.jpg GRAPHIC 2862
6 GRAPHIC image_002.jpg GRAPHIC 6666
7 GRAPHIC image_003.jpg GRAPHIC 19883
8 GRAPHIC image_004.jpg GRAPHIC 12425
9 GRAPHIC image_005.jpg GRAPHIC 13835
10 GRAPHIC image_006.jpg GRAPHIC 15308
11 GRAPHIC image_007.jpg GRAPHIC 23887
12 GRAPHIC image_008.jpg GRAPHIC 10246
13 GRAPHIC image_009.jpg GRAPHIC 15099
14 GRAPHIC image_010.jpg GRAPHIC 9358
15 GRAPHIC image_011.jpg GRAPHIC 14006
16 GRAPHIC image_012.jpg GRAPHIC 16351
17 GRAPHIC ex5-1_001.jpg GRAPHIC 10262
  Complete submission text file 0001213900-22-076486.txt   2544280
Mailing Address 27 STRATHMORE RD NATICK MA 01760
Business Address 27 STRATHMORE RD NATICK MA 01760 917-361-8514
Felicitex Therapeutics Inc. (Filer) CIK: 0001912287 (see all company filings)

IRS No.: 811036062 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-266742 | Film No.: 221436720
SIC: 2834 Pharmaceutical Preparations